Cargando…
Rad6 is a Potential Early Marker of Melanoma Development
Melanoma is the leading cause of death from skin cancer in industrialized countries. Several melanoma-related biomarkers and signaling pathways have been identified; however, their relevance to melanoma development/progression or to clinical outcome remains to be established. Aberrant activation of...
Autores principales: | Rosner, Karli, Adsule, Shreelekha, Haynes, Brittany, Kirou, Evangelia, Kato, Ikuko, Mehregan, Darius R., Shekhar, Malathy P.V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4145396/ https://www.ncbi.nlm.nih.gov/pubmed/24831578 http://dx.doi.org/10.1016/j.tranon.2014.04.009 |
Ejemplares similares
-
Melanoma Development and Progression Are Associated with Rad6 Upregulation and β-Catenin Relocation to the Cell Membrane
por: Rosner, Karli, et al.
Publicado: (2014) -
RAD6 inhibition enhances paclitaxel sensitivity of triple negative breast cancer cells by aggravating mitotic spindle damage
por: Haynes, Brittany M., et al.
Publicado: (2022) -
Alternative Splicing of RAD6B and Not RAD6A Is Selectively Increased in Melanoma: Identification and Functional Characterization
por: Gajan, Ambikai, et al.
Publicado: (2019) -
Rad6B acts downstream of Wnt signaling to stabilize β-catenin: Implications for a novel Wnt/β-catenin target
por: Gerard, Brigitte, et al.
Publicado: (2011) -
Comedo-DCIS is a precursor lesion for basal-like breast carcinoma: identification of a novel p63/Her2/neu expressing subgroup
por: Shekhar, Malathy P.V., et al.
Publicado: (2013)